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We present a system for creating influenza virus by generating viral RNA (vRNA) and mRNA from one template. Recently,
a system for the generation of influenza A virus entirely from cloned cDNAs was established (Neumann et al., 1999, Proc.
Natl. Acad. Sci. USA 96, 9345–9350). Cells were transfected with plasmids for RNA polymerase I-driven intracellular
synthesis of all eight viral RNAs, and with protein expression plasmids for the synthesis of viral structural proteins. Although
this system is highly efficient in virus generation, the construction and cotransfection of 17 plasmids is cumbersome and may
limit the use of this system to cell lines that can be transfected with high efficiencies. Synthesizing both vRNA and mRNA
from one template would reduce the number of plasmids required for virus generation. Therefore, we generated a
bidirectional transcription construct that contains cDNA encoding PB1 flanked by an RNA polymerase I (pol I) promoter for
vRNA synthesis and an RNA polymerase II (pol II) promoter for mRNA synthesis. The utility of this approach is proved by the
generation of virus after transfecting the pol I/pol II-promoter–PB1 construct together with vRNA- and protein-expression
constructs for the remaining seven segments. Because this approach reduces the number of plasmids required for virus
generation, it also reduces the work necessary for cloning, probably enhances the efficiency of virus generation, and expands
the use of the reverse-genetics system to cell lines for which efficient cotransfection of 17 plasmids cannot be achieved.
© 2000 Academic PressINTRODUCTION
Influenza A virus is a negative-strand RNA virus with a
segmented genome consisting of eight viral RNA seg-
ments. The genomic RNAs contain one or more open
reading frames that are flanked by noncoding sequences
at the 59 and 39 ends of the RNA molecules (Dessel-
berger et al., 1980). The viral RNAs are associated with
viral NP and polymerase proteins (PB1, PB2, and PA) in
virions and in infected cells to form ribonucleoprotein
(RNP) complexes (Hsu et al., 1987). After the RNP com-
lexes enter the nucleus, the RNA segments are repli-
ated and transcribed to yield three types of RNA mole-
ules. The vRNA is transcribed into cRNA, which is
opied into vRNA. The vRNA serves as template for the
ynthesis of mRNA, from which viral proteins are trans-
ated. Late in the life cycle, the genomic RNAs and
roteins are packaged into new progeny virus particles
hat can start a new replication cycle.
Several methods have been developed for genetic
ngineering of influenza A viruses (Luytjes et al., 1989;
Zobel et al., 1993). The ribonucleoprotein (RNP) transfec-
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310tion system developed by Palese and coworkers (Luytjes
et al., 1989; Enami et al., 1990) is based on the in vitro
transcription reaction for synthesis of RNA molecules.
RNP complexes are made by incubating the RNA tran-
scripts with purified nucleoprotein and the three poly-
merase subunits (PB1, PB2, PA). After the reconstituted
RNP complexes are transfected into eukaryotic cells, a
helper virus is used as the source of the proteins needed
for replication of the recombinant RNP molecules.
Hobom and coworkers (Zobel et al., 1993; Neumann et
al., 1994) developed a system based on the precise
transcription of an influenza virus cDNA template by the
cellular RNA polymerase I (pol I) complex. In this system,
the viral cDNA is inserted between a pol I-promoter and
terminator sequence. After in vivo synthesis of genomic
influenza-like RNA molecules, the nucleoprotein and
polymerase proteins are delivered by infection with
helper virus, thus forming functional RNPs in mouse or
primate cells (Neumann et al., 1994; Hoffmann, 1997).
Pleschka and colleagues (1996) also used a pol I-pro-
moter for the transcription of viral cDNA, but the 39 end of
the viral RNA was generated by the autocatalytic cleav-
age of a hepatitis delta ribozyme sequence. However,
the potential use of the RNP- and the DNA-transfection
methods is limited, because of the use of a helper virus,
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311GENERATION OF INFLUENZA A VIRUSwhich requires a strong selection system to obtain the
desired virus from a vast background of helper virus.
In a previous study, a plasmid-based system was used
to provide both viral RNA and viral proteins for the gen-
eration of influenza A viruses without helper virus infec-
tion (Neumann et al., 1999). This reverse-genetics system
proved to be highly efficient for the generation of the
A/WSN/33 (H1N1) virus in 293T cells. However, this sys-
tem, which contains the pol I and pol II promoters with
the influenza virus cDNAs on different plasmids, requires
the construction of at least 12 plasmids for efficient virus
recovery. Transfection of cells with this many plasmids
may limit the use of this system to cell lines which have
a high transfection efficiency. To be able to rescue virus
from different cell types may increase the virus yield by
enhancing the replication of influenza A virus in these
cells and increase the range of cells suitable for the
production of vaccines (Govorkova et al., 1996). As a first
step in reducing the number of plasmids, we report here
the construction and transfection of plasmids containing
both the pol I- and pol II-promoter on the same plasmid
and present evidence that this system allows the expres-
sion of vRNA and protein from one template.
RESULTS AND DISCUSSION
Design and features of the cloning vector pHW12
containing two eukaryotic promoters
Influenza A viruses are segmented viruses that con-
tain RNA molecules with negative-sense polarity. During
the replication cycle, recognition of the 59- and 39-struc-
tures of the eight vRNA segments by the ribonucleopro-
tein complex proteins (PB2, PB1, PA, NP) results in the
replication and transcription of the influenza virus genes.
The fact that the terminal sequence elements are highly
conserved indicates that a transcribed artificial RNA
should have sequences that are the same as those of the
59 and 39 ends (Luo et al., 1991; Flick et al., 1996). The
cloning vector pHW12 was constructed, allowing the
insertion of sequences of interest between the pol I-pro-
moter and terminator by using the restriction endonucle-
ase BsmBI (see Fig. 1A). The pol I-transcription unit is
flanked by the pol II-promoter from the cytomegalovirus
(CMV) and by the polyadenylation signal of the gene
encoding bovine growth hormone. The CMV-promoter,
the poly A site, and the backbone of the plasmid are
derived from the cloning vector pcDNA3.
PB1 protein expression in the pol I/pol II bidirectional
transcription system
To test the pol I/pol II one-plasmid transcription sys-
tem, we inserted the cDNA of the PB1 gene of A/WSN/33
virus into the cloning vector pHW12 to yield the plasmid
pHW52-PB1 (Fig. 1B). HindIII and XhoI restriction sites
t
awere inserted into the 59 and 39 noncoding regions of this
gene. These genetic tags were included to ensure that
the generated recombinant virus could be identified by
RT-PCR. We expected that human cells transfected with
this plasmid would yield two types of RNA (Fig. 1B):
PB1-vRNA, synthesized by cellular pol I; and an mRNA
with a 59-cap structure, synthesized by the pol II. Trans-
lation of the mRNA should result in the synthesis of
PB1-protein.
To examine whether the PB1-protein is produced from
this construct, we tested replication and transcription of
an artificial vRNA by constructing the expression plas-
mids pHW21-PB2, pHW23-PA, and pHW25-NP, which
contain cDNAs encoding PB2, PA, and NP proteins of
A/WSN/33 under the control of the CMV-promoter. For
the in vivo synthesis of an artificial vRNA, we constructed
the reporter plasmid pHW72-EGFP (Fig. 2A), containing
the EGFP cDNA flanked by the noncoding region of the
M-segment and the human pol I-promoter and the mu-
rine terminator sequence. Five plasmids (2 mg pHW21-
B2, 2 mg pHW52-PB1 [pol I/pol II-promoter construct], 2
mg pHW23-PA, 2 mg pHW25-NP, and 1 mg pHW72-EGFP)
ere transfected into 293T cells. Twenty-four and 48 h
fter transfection, the cells were analyzed by fluores-
ence microscopy. After 24 h, fluorescent cells were
bserved (data not shown). This result shows that within
4 h the polymerase proteins are synthesized in a con-
entration sufficient to allow recognition of the influenza
irus-specific ends of the EGFP-vRNA. These proteins
ynthesize mRNA, which is translated into EGFP.
To evaluate the efficiency of this system, we performed
low cytometric analysis to count the number of fluores-
ent cells (Fig. 2B). Forty-eight hours after transfection of
he five plasmids, 18.72% of the cell population showed
luorescence. Only a background level of fluorescent
ells (0.06%) was observed when pHW52-PB1 plasmid
as not added; this finding is consistent with those of
arlier studies, which showed that all four RNP-complex
roteins are necessary for the amplification of the vRNA
Huang et al., 1990). The results indicate that the PB1-
DNA transcription and the resulting concentration of
B1 protein together with the other RNP complex pro-
eins is sufficient to initiate a viral transcription/replica-
ion process.
eneration of recombinant influenza A virus
For the generation of infectious influenza A virus, it is
ecessary that the plasmid pHW52-PB1 provides not
nly PB1 mRNA and protein but also sufficient amounts
f PB1-vRNA, which can be packaged into progeny virus
Fig. 1B). For the remaining seven vRNAs, we used plas-
ids that contain the cDNAs for the full-length RNAs ofhe A/WSN/33 virus, flanked by the human pol I-promoter
nd the murine terminator. Transfection of these plas-
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FIG. 1. The pol I/pol II bidirectional transcription system. (A) The clo
(pIICMV) of the human cytomegalovirus and the polyadenylation signal (
elements is a murine terminator (tI) and the sequence of the human RN
the pol I promoter and terminator, two BsmBI restriction sites were intr
but noncomplementary 59 protruding ends is generated. For propaga
lactamase gene (bla) for selection in ampicillin-containing medium. (B) T
transfection. The plasmid is derived from pHW12. cDNA of the PB1-seg
epresents the sequence for the ORF of the PB1 gene. Between the in
B1 gene, sequences containing HindIII and XhoI restriction sites ha
olecules are expected to be synthesized. From the human pol I prom
olymerase I, and this transcription results in an influenza-like vRNA m
nds. Transcription by RNA polymerase II is expected to result in an m
rotein after translation.that are replicated and transcribed by the polymerase
proteins, forming new vRNPs. After synthesis of thestructural proteins, the RNPs would be packaged into
ector pHW12. The plasmid contains the RNA polymerase II promoter
of the gene encoding bovine growth hormone. Inserted between these
merase I promoter (pIh). For insertion of arbitrary sequences between
. After digestion with BsmBI, a vector fragment (bold type) with sticky
E. coli, the plasmid contains an origin of replication (ori) and a beta
ression plasmid pHW52-PB1 and proposed transcription products after
inserted between the pol I promoter (pIh) and terminator (tI). The arrow
virus-specific noncoding region (NCR) and the coding region for the
inserted. After transfection of this expression plasmid, two types of
A with the 59 and 39 noncoding region is transcribed by cellular RNA
le with recognition elements for the viral polymerase proteins at both
ith a 59 cap structure and a 39 poly A tail; this mRNA expresses PB1ning v
aIIBGH)
A poly
oduced
tion in
he exp
ment is
fluenza
ve been
oter, RN
olecu
RNA wnew virus particles.
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313GENERATION OF INFLUENZA A VIRUSamounts of pHW52-PB1 plasmid (0, 2, and 4 mg) together
ith the plasmids pPolI-WSN-PB2, pPolI-WSN-PA, pPolI-
SN-HA, pPolI-WSN-NP, pPolI-WSN-NA, pHW127-M, and
HW128-NS (1 mg each). The protein-expression plas-
ids pHW21-PB2 (1 mg), pHW23-PA (0.1 mg), pHW25-NP
1 mg), pEWSN-HA (1 mg), and pCAGGS-WNA15 (1 mg)
ere cotransfected. The expression plasmids for the
emagglutinin (HA) and the neuraminidase (NA) were
ncluded to increase the yield of transfectant virus.
Forty-eight hours after transfection, the supernatant of
he primary transfected 293T cells was transferred to
DCK cells. In all transfection experiments in which
HW52-PB1 plasmid was added, 24 h after the passage
e observed a virus-induced cytopathic effect. No cyto-
FIG. 2. Flow cytometric evaluation of the efficiency of the plasmid-
reporter plasmid pHW72-EGFP with a pol I-transcription unit containin
encoding EGFP. (B) We transfected 293T cells with the indicated plasm
fluorescent cells. Upper panel: flow cytometric analysis after trans
pHW52-PB1; lower panel: analysis after transfection with pHW52-PB
fluorescent cells.athic effect was visible if no PB1-expressing plasmid
as included in the transfection reaction. The virus titer uas determined by titrating the supernatant of the trans-
ected cells on MDCK cells; the supernatant was found to
ontain 2 3 104–2 3 105 pfu/ml. This finding shows that,
fter transfection of the PB1-pol I/pol II-promoter plasmid
together with the expression plasmids), PB1 vRNA and
B1 protein are synthesized in the human cell line 293T
t a level sufficient for the generation of infectious influ-
nza A viruses. In the cotransfection experiments (Table
) with plasmids containing the PB1-cDNA separated on
wo plasmids (pHW82-PB1 and pHW22-PB1), a virus titer
f 2 3 104 pfu/ml was found; the analogous experiment
sing the plasmids with wild-type PB1 sequences (pPol
-WSN-PB1 and pHW22-PB1) resulted in a virus titer of
3 106 pfu/ml.
pol I/pol II transcription system. (A) Schematic representation of the
equences of the noncoding region of the M segment and the cDNA
h later, we used flow cytometric analysis to determine the number of
of pHW21-PB2, pHW23-PA, pHW25-NP, and pHW72-EGFP without
bar M1 represents the region used to determine the percentage ofbased
g the s
ids; 48
fectionUnlike the expression construct with a pol II-promoter
sed in a previous study (Neumann et al., 1999), we used
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314 HOFFMANN ET AL.the plasmid pHW52-PB1 (Fig. 1B) that contains se-
quences derived from the pol I-transcription unit that are
inserted between the CMV-promoter and the polyadenyl-
ation site. The expression of the EGFP reporter gene
demonstrates that the overall expression of PB1-protein
in this system is sufficient for formation of EGFP–RNP
complexes. Although the pol I-promoter/terminator re-
gion contains recognition sequences for pol I-specific
transcription and termination factors (Bell et al., 1988;
Kuhn et al., 1994; Beckmann et al., 1995), these DNA-
inding proteins do not seem to inhibit pol II-mediated
ranscription. These findings are consistent with the find-
ng that the pol I-specific DNA-binding proteins are more
bundant in the nucleolus, the compartment in which the
ellular rDNA-transcription takes place (Evers et al.,
995). These results indicate that after transfection of the
ol I/pol II-promoter construct into the cell, some of the
lasmids are delivered to the nucleolus, where the pol
-mediated transcription occurs, and some are retained
n the nucleus, where they are transcribed by RNA poly-
erase II.
Because the reporter construct pHW52-PB1 contained
dditional noninfluenza virus sequences (restriction
ites) in the noncoding region before the start codon and
fter the stop codon, we were interested as to whether
hese sequences were stably maintained in the viral PB1
NA segment (Fig. 3A). Therefore, we isolated vRNA
fter the second passage of transfectant virus on MDCK
ells and performed reverse-transcription PCR analysis.
T
Plasmid Sets Used for Recove
Plasmid Promoter cDNA
HW21-PB2 pol II PB2 1
HW22-PB1 pol II PB1 —
HW23-PA pol II PA 0
HW25-NP pol II NP 1
EWSNHA pol II HA 1
CAGGS-WNA15 pol II NA 1
Poll-WSN-PB2 pol I PB2 1
HW82-PB1 pol I PB1a —
pPoll-WSN-PB1 pol I PB1 —
pPoll-WSN-PA pol I PA 1
pPoll-WSN-NP pol I NP 1
pPoll-WSN-HA pol I HA 1
pPoll-WSN-NA pol I NA 1
pHW127-M pol I M 1
pHW128-NS pol I NS 1
pHW52-PB1 pol I 1 pol II PB1a 0
Virus titer (pfu/ml) 0
Note. 293T cells were transfected with the indicated plasmids; the v
a The cDNA contains additional noninfluenza A virus sequences ins shown in Fig. 3B, the amplification of vRNA with
B1-specific primers resulted in the generation of cDNA
t
Pragments of the expected sizes. With the same viral RNA
nd primers, but without the addition of reverse-tran-
criptase, no amplification product was obtained, show-
ng that the cDNA originated from viral RNA and not from
lasmid DNA carried over from the supernatant of trans-
ected cells. Sequencing of the PCR products revealed
hat both restriction site sequences were present in the
NA molecule. The results show that the pol I/pol II-
ranscription system allows recovery of infectious recom-
inant virus and that virus with foreign sequences in the
oncoding region of the PB1 gene is viable. This modi-
ied-PB1 segment is still replicated, transcribed, and
ackaged into virus particles. Previously, by using the
NP-transfection system, the noncoding regions of influ-
nza A virus segments were changed. By substituting the
oncoding region of the NA gene with the corresponding
equence of the NS segment of influenza B, transfectant
nfluenza viruses were obtained (Muster et al., 1991;
ergmann and Muster, 1995). This type of virus with a
himeric NA segment showed an attenuated phenotype
n mice and protected mice inoculated with a nonlethal
ose against infection of the wild-type influenza virus
nfection. These results showed that the genetic alter-
tion of the noncoding region of an RNA segment can
hange the biological property of a transfectant virus.
ere, we report for the first time that even noninfluenza
irus sequences can be inserted into the noncoding
egion of the PB1 segment. With the pol I/pol II-transcrip-
ion system, it is now possible to systematically modify
ecombinant Influenza A Virus
mg-Transfected plasmid DNA
1 1 1 1
— — 1 1
0.1 0.1 0.1 0.1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
— — 1 —
— — — 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
2 4 — —
2 3 104 2 3 105 2 3 104 3 3 106
er in the cell culture supernatants was determined in MDCK cells.
coding region of the PB1 segment.ABLE 1
ry of R
.1hese sequence elements in the noncoding region of the
B1 segment and to evaluate whether these genetic
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315GENERATION OF INFLUENZA A VIRUSmanipulations result in changes in the biological prop-
erties of the recombinant viruses. Indeed, the lower yield
of the viruses with the mutated PB1 segment compared
to the wild-type virus indicates that the inserted se-
quences negatively influence the virus growth.
Although the plasmid-based system developed re-
cently (Neumann et al., 1999) is highly efficient in gener-
FIG. 3. Detection of recombinant influenza A virus by RT-PCR. (A)
Schematic representation of the recombinant PB1 RNA segment and
the location of primers used for RT-PCR. The sequences (shown in
cRNA orientation) above the RNA segment represent the introduced
noninfluenza virus sequences before the start codon (AAGCUU) and
after the stop codon (CUCGAG). The primers used in the RT-PCR
reaction are represented by arrows. The expected sizes of the frag-
ments at the 59 and 39 parts are shown in brackets. (B) RT-PCR reaction
as performed with primers specific for the PB1 gene segment and
ith vRNA extracted from virions. The reaction products were sub-
ected to electrophoresis on a 2% agarose gel. To ensure that the
mplified DNA fragments were derived from vRNA, and not from plas-
id DNA carried over from transfected cells, one reaction was per-
ormed without the addition of reverse-transcriptase (2). Lanes 1 and
: reactions using the primers Bm-PB1–1 and Seq-PB1#1; lanes 3 and
: reactions using Seq-PB1#2 and Bm-PB1–2341R; M: 100-bp ladder
Promega). The presence of the inserted sequences was verified by
equencing the amplified DNA fragments.ting influenza virus, it involves cloning of 14 to 17 plas-
ids. In this study, we reduced the number of plasmids
H
mto 13, which are needed for the efficient recovery of
influenza A/WSN/33 virus strain. The reduction in the
number of plasmids achieved by this approach promises
to increase the efficiency of transfection for cell lines
other than 293T cells, thus allowing the delivery of genes
to cell lines for which the efficient delivery of 14 plasmids
is difficult to achieve. Fodor et al. (1999) were able to
rescue influenza virus after transfecting 12 plasmids; the
virus yield in this study was 1–2 infectious virus particles
per 106 transfected Vero cells. It would be interesting to
nvestigate whether the pol I/pol II-transcription system,
n addition to the transcription of PB1-cDNA, can also be
sed for the remaining seven RNA segments. Such in-
estigations could test whether the pol I/pol II bidirec-
ional transcription system allows the development of a
lasmid-based system that contains eight plasmids for
he production of influenza A viruses, thus improving this
everse-genetics system by decreasing the time and cost
equired for genetic engineering of influenza A viruses. It
ould also be interesting to investigate whether the
ransfection system containing a pol I- and pol II-pro-
oter on the same plasmid is applicable for the gener-
tion of other orthomyxoviruses (i.e., influenza B,
hogotovirus).
MATERIALS AND METHODS
loning of plasmids
All cloning and PCR reactions were performed accord-
ng to standard protocols. Briefly, the expression plas-
ids for the polymerase-complex genes of A/WSN/33
ere derived from pcDNA3 (Invitrogen, La Jolla, CA)
ontaining the immediate early promoter of the human
ytomegalovirus (CMV) and the poly A site of the gene
ncoding bovine growth hormone (BGH). The viral cD-
As were derived from the plasmids pWNP143, pWS-
PA3, pWSNPB2–14, and pGW-PB1 (kindly provided by
. Nayak) to yield the expression constructs pHW25-NP,
HW23-PA, pHW21-PB2, and pHW22-PB1, respectively.
HW12 was generated by inserting human pol I-pro-
oter and terminator sequences between the pol II-
romoter and the polyA-site (Fig. 1A). The plasmid
HW52 was derived from pHW12 by first inserting oligo-
ucleotides containing the noncoding region of PB1 ex-
ended by HindIII and XhoI sites and then inserting the
B1-coding region from pHW22-PB1 into these sites (Fig.
B). The plasmid pHW82-PB1 was derived from pHW52-
B1 by deletion of the CMV-promoter sequences. The
oding region for the enhanced green fluorescent protein
EGFP) in the reporter construct pHW72-EGFP was ob-
ained after PCR-amplification using pEGFP-N1 (Clon-
ech, Palo Alto, CA) as template and inserting the cDNA
fter SacII/XhoI digestion into the plasmid pHW72 (E.
offmann, unpublished) containing the human pol I-pro-
oter and murine terminator and the noncoding region
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316 HOFFMANN ET AL.of the M-segment separated by SacII/XhoI sites (Fig. 2A).
pHW127-M and pHW128-NS were constructed by RT-
PCR amplification of viral RNA with the primers contain-
ing segment-specific sequences and BsmBI sites for
insertion into the BsmBI-digested vector pHH21 (Hoff-
mann, 1997; Neumann et al., 1999). All sequences of the
oligonucleotides for PCR amplification or cloning are
available on request. The construction of the plasmids
pPolI-WSN-PB1, pPolI-WSN-PB2, pPolI-WSN-PA, pPolI-
WSN-NP, pPolI-WSN-HA, pPolI-WSN-NA, pEWSN-HA,
and pCAGGS-WNA15 has been described elsewhere
(Neumann et al., 1999).
Cell culture and transfection
Madin–Darby canine kidney (MDCK) cells were main-
tained in modified Eagle medium (MEM) containing 10%
fetal bovine serum (FBS); 293T human embryonic kidney
cells were cultured in Dulbecco’s modified Eagle me-
dium (DMEM) containing 10% FBS. TransIT LT-1 (Pan-
vera, Madison, WI) was used according to the manufac-
turer’s instructions to transfect 1 3 106 293T cells. Dif-
ferent amounts of plasmids (Table 1) were mixed with
TransIT LT-1 (2 ml TransIT LT-1 per 1 mg of DNA), incu-
ated at room temperature for 45 min and added to the
ells. After 6 h, the DNA-transfection mixture was re-
laced by Opti-MEM (Gibco/BRL, Gaithersburg, MD),
ontaining 0.3% bovine serum albumin (BSA) and 0.01%
BS. Forty-eight hours after transfection, supernatants
ontaining virus were titrated in MDCK cells.
NA isolation and RT-PCR
Viral RNA was isolated from virus particles with the
se of the RNeasy-Kit (Qiagen, Valencia, CA) according
o the manufacturer’s instructions. For characterization of
ecombinant influenza viruses, the Access RT-PCR kit
Promega, Madison, WI) was used according to the pro-
ocol provided. The following primers were used in the
T-PCR experiments: Seq-PB1#1: 59-AGG ATG GGA TTC
TC AAG G-39; Seq-PB1#2: 59-GCT ATG GTT TCC AGA
CC CG-39; Bm-PB1–1: 59-TAT TCG TCT CAG GGA GCG
AA GCA GGC A-39; Bm-PB1–2341R: 59-ATA TCG TCT
GT ATT AGT AGA AAC AAG GCA TTT-39. RT-PCR ex-
eriments were performed by using the PTC-200 DNA
ngine (MJ Research, Watertown, MA). The amplification
rogram started with one cycle at 48°C for 45 min (first-
trand cDNA synthesis) and one cycle at 94°C for 2 min
inactivation of the AMV reverse-transcriptase and cDNA
enaturation). These cycles were followed by 40 cycles
t 94°C for 20 s, 52°C for 30 s, and 72°C for 30 s (PCR
mplification); the program ended with one cycle at 72°C
or 5 min. The PCR products were analyzed by agarose
el electrophoresis and sequenced with the primer Seq-
B1#1 or Seq-PB1#2 (Fig. 3).low cytometry
Forty-eight hours after transfection, 293T cells were
ashed with phosphate-buffered saline (PBS), pelleted,
nd resuspended in PBS plus 5% FBS. Flow cytometric
nalysis was performed by using a FACSCalibur flow
ytometer (Becton-Dickinson) and the data were ana-
yzed by using the CellQuest software package. For
GFP expression analysis, we used the emission wave-
ength of 530 nm (FL1) to achieve a high sensivity for
GFP-mediated fluorescence detection.
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